Navigation Links
As Pradaxa Lawsuits Move Forward, Bernstein Liebhard LLP Notes Manufacturer is Working on Possible Antidote for Internal Bleeding Caused by the Blood-Thinner
Date:12/4/2013

New York, New York (PRWEB) December 04, 2013

As nearly 2,000 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) alleging injuries due to internal bleeding continue to move forward in federal court, Bernstein Liebhard LLP notes that Boehringer Ingelheim Pharmaceuticals, the manufacturer of the blood-thinner, has announced results from a clinical trial of a possible antidote to reverse dangerous internal bleeding that can sometimes accompany use of the drug. According to a recent Reuters report, the early stage trial involving 150 healthy volunteers indicated that the antidote worked “immediately and completely.” However, larger trials will be needed to prove the antidote’s safety and effectiveness.*

“This is an interesting development, as a lack of an effective antidote for internal bleeding is a key factor in hundreds of Pradaxa lawsuits currently pending against Boehringer Ingelheim. Unfortunately, the availability of any such antidote will have come too late for the alleged victims of Pradaxa,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding side effects.

Pradaxa Lawsuits
According to court documents, just over 1,900 Pradaxa lawsuits are currently pending in the federal multidistrict litigation underway in U.S. District Court, Southern District of Illinois. All of the claims were filed on behalf of alleged victims of Pradaxa bleeding side effects. Among other things, the lawsuits allege that Boehringer Ingelheim failed to provide adequate warnings regarding the lack of an antidote for internal bleeding caused by the medication. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

According to Bernstein Liebhard,
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Pradaxa Lawsuit News: Wright & Schulte LLC Reports on Growing Pradaxa Bleeding Litigation, As Number of Filings Exceed 1,800
2. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on November Status Conference in Federal Pradaxa Bleeding Litigation
3. Pradaxa Bleeding Allegations Lawyer: Resource4thePeople Reports New Study May Produce Treatment to Reverse Anti-Clotting Medication Effects
4. Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
5. Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation
6. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
7. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
8. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
9. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
10. Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar
11. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 On February 24 2015, ... Liquid Botox ,” that details the development of RT001, ... working its way through FDA trials. For those afraid of ... is very attractive. Of course, if the drug ultimately gets ... a physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The winter season ... growth and expansion. When mold grows, it can be harmful ... sure to avoid the consequences of mold growth with the ... Island, is offering tips on the best ways to prevent ... season, which makes perfect conditions for mold to thrive. Mold ...
(Date:2/27/2015)... February 27, 2015 Florida Hospital North ... Guidelines - Stroke Gold Plus hospital. In order to ... or higher adherence to all Get With The Guidelines ... consecutive 12-month intervals and achieved 75-percent or higher compliance ... Stroke Quality Measures. These are reporting initiatives to measure ...
(Date:2/27/2015)... The Nashville periodontist office, ... for rising freshmen undergraduate students. , The Advanced Institute ... in many periodontal procedures such as dental implants ... disease . In honor of their 25th anniversary, AIOH ... rising freshmen undergraduate students. , Students interested in ...
(Date:2/27/2015)... Raton, FL (PRWEB) February 27, 2015 ... diagnostic testing company that provides vascular, echocardiogram and ... proud to be the preferred diagnostic testing provider ... University, a coeducational public liberal arts university in ... by the Wimbledon U collegiate division, ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 3
... could lose brain function earlier than is noticeably detectable, ... Physicians need a method to assess these sensitive changes ... tests. Penn State College of Medicine researchers created ... in judgment and problem-solving in ALS patients. FTD is ...
... June 22 (HealthDay News) -- Heart damage caused by heavy ... a new study. Researchers assessed the heart health of ... drug rehabilitation program 48 hours after they last used cocaine. ... years and consumed about 5.5 grams of cocaine per day. ...
... , TUESDAY, June 21 (HealthDay News) -- High doses of ... a downside. A new meta-analysis finds that intensive doses ... of being diagnosed with type 2 diabetes compared with moderate ... revealed a lower incidence of heart attacks, stroke and death, ...
... By Alan Mozes HealthDay Reporter , TUESDAY, ... play date, American parents may want to ask if there ... The reason: almost 2 million American homes with kids contain ... each year from unintentional shootings. That,s why the Center ...
... HealthDay Reporter , TUESDAY, June 21 (HealthDay News) ... and psoriasis may help patients with these autoimmune disorders ... New research found that a particular class of disease-modifying ... inhibitors and the antimalarial drug hydroxychloroquine can reduce ...
... By Alan Mozes HealthDay Reporter , TUESDAY, June ... research suggests that repeated bouts of unemployment don,t affect everyone ... people who are consistently successful in finding new work after ... so-called "serial joblessness" than are those who lose a job ...
Cached Medicine News:Health News:Brief exam diagnoses cognitive impairment in ALS patients 2Health News:Cocaine-Related Heart Damage May Be 'Silent' 2Health News:High-Dose Statins May Increase Diabetes Risk 2Health News:High-Dose Statins May Increase Diabetes Risk 3Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 2Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 3Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 4Health News:Some Drugs for Rheumatoid Arthritis, Psoriasis May Cut Diabetes Risk 2Health News:Some Drugs for Rheumatoid Arthritis, Psoriasis May Cut Diabetes Risk 3Health News:Unemployment May Hit Some Harder Than Others 2Health News:Unemployment May Hit Some Harder Than Others 3Health News:Unemployment May Hit Some Harder Than Others 4
(Date:2/27/2015)... TORONTO , Feb. 27, 2015  Bionik Laboratories ... (the "Company"), announced today that it acquired Bionik Laboratories, ... Laboratories"), and completed the sale to qualified accredited investors ... for aggregate gross proceeds of approximately $6.2 million. Shares ... quoted on the OTC Markets under the symbol "DWTPD" ...
(Date:2/26/2015)... , February 27, 2015 ... 2014 market research report to its store. This ... Ulcers, therapeutic pipeline. The report "Corneal ... the therapeutic development for Corneal Ulcers. Corneal Ulcers ... includes bacterial infections, viral infections & fungal infections. ...
(Date:2/26/2015)...  IRIDEX Corporation (NASDAQ: IRIX ) today announced ... 2014 financial results after the market closes on Thursday, ... Company will host a conference call with the investment community ... March 5, 2015 to discuss the results of the ... access the live conference call via telephone by dialing (877) ...
Breaking Medicine Technology:Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
... Group (MRG), the global authority on medical technology ... research data for multiple geographies, including the US, ... MRG,s peripheral vascular reports cover minimally invasive ... stenting, percutaneous transluminal balloon angioplasty, and synthetic surgical ...
... RO, ROG; OTCQX: RHHBY) and study investigators from Harvard ... the PROTECT ( Pr o-BNP O utpatient ... T herapy) trial, a strategy of NT-proBNP guided heart ... in total cardiovascular events, the primary composite endpoint of ...
Cached Medicine Technology:New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group 2NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events 2NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events 3
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
Medicine Products: